SCHEMBL843044

SCHEMBL843044

CCN(CC)c1cc(C)nc2cnnn12

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.51
CYP1A2 P05177 1/20 0.51
MAPK1 P28482 1/20 0.51
CRHR1 P34998 18/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2491412 0.73 PIK3CG (0.48)
SCHEMBL7706336 0.72 LMNA (0.33) LMNACYP1A2MAPK1
SCHEMBL7712320 0.72 CRHR1 (0.34) LMNACYP1A2MAPK1CRHR1
SCHEMBL10407901 0.70 PIK3CG (0.34) LMNA
SCHEMBL9664890 0.70 PIK3CG (0.34) LMNA
SCHEMBL9038706 0.70 RAB9A (0.41) LMNA
SCHEMBL5241060 0.70 PIK3CG (0.34) LMNA
SCHEMBL7712313 0.69 HTT (0.35) LMNACRHR1
SCHEMBL10911368 0.68 CYP1A2 (0.55) LMNACYP1A2MAPK1CRHR1
Trapidil SCHEMBL19438921 0.68 MAPK1 (1.00) LMNACYP1A2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6369065-B1 CEREBROVASCULAR AND CARDIOVASCULAR DISORDERS UCB S.A. (BE) 2002-04-09 US claimed
JP-56079674-A None JP disclosed
JP-59029689-A None JP disclosed
JP-58174384-A None JP disclosed
EP-3165606-A1 METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL DISEASES Ophthotech Corporation (US) 2017-05-10 EP disclosed
US-20120100136-A1 METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL DISEASES OPHTHOTECH CORPORATION (US) 2012-04-26 US disclosed
EP-2432476-A1 METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL DISEASES Ophthotech Corporation (US) 2012-03-28 EP disclosed
US-6369065-B1 CEREBROVASCULAR AND CARDIOVASCULAR DISORDERS UCB S.A. (BE) 2002-04-09 US disclosed
EP-0568451-B1 Thermoplastic polymer composition and medical devices made of the same TERUMO CORP (JP) 1999-08-04 EP disclosed
EP-0810217-A1 Pyrazole derivatives and their pharmaceutical use as smooth muscle cell growth inhibitors JAPAN ENERGY CORPORATION (JP) 1997-12-03 EP disclosed
US-5417981-A Polymer and protease inhibitor formed by melt kneading the mixture TERUMO KABUSHIKI KAISHA (JP) 1995-05-23 US disclosed
EP-0568451-A1 Thermoplastic polymer composition and medical devices made of the same TERUMO KABUSHIKI KAISHA (JP) 1993-11-03 EP disclosed
EP-0302132-B1 Process and device for the preparation of 5-methyl-7-diethyl amino-s-triazolo[1,5-a] pyrimidine Deutsche Hydrierwerke GmbH Rodleben (DE) 1991-04-03 EP disclosed
EP-0302132-A1 Process and device for the preparation of 5-methyl-7-diethyl amino-s-triazolo[1,5-a] pyrimidine Deutsche Hydrierwerke GmbH Rodleben (DE) 1989-02-08 EP disclosed
EP-0302132-A1 Process and device for the preparation of 5-methyl-7-diethyl amino-s-triazolo[1,5-a] pyrimidine Deutsche Hydrierwerke GmbH Rodleben (DE) 1989-02-08 EP disclosed
EP-0075029-B1 AGENT FOR TREATING CHRONIC OBLITERATIVE LUNG DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1986-10-29 EP disclosed
JP-S5929689-A PURIFICATION OF 5-METHYL-7-DIETHYLAMINO-S-TRIAZOLO(1,5-A) PYRIMIDINE MITSUI PETROCHEM IND LTD 1984-02-16 JP disclosed
JP-S58174384-A PURIFICATION METHOD OF 5-METHYL-7-DIETHYLAMINO-S-TRIAZOLO (1,5-A)PYRIMIDINE MITSUI PETROCHEM IND LTD 1983-10-13 JP disclosed
JP-S5679674-A PREPARATION OF AMINO GROUP-CONTAINING PYRIMIDINE DERIVATIVE MITSUI PETROCHEM IND LTD 1981-06-30 JP disclosed